DE69417252D1 - Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 - Google Patents

Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17

Info

Publication number
DE69417252D1
DE69417252D1 DE69417252T DE69417252T DE69417252D1 DE 69417252 D1 DE69417252 D1 DE 69417252D1 DE 69417252 T DE69417252 T DE 69417252T DE 69417252 T DE69417252 T DE 69417252T DE 69417252 D1 DE69417252 D1 DE 69417252D1
Authority
DE
Germany
Prior art keywords
pro
against human
immunogenic composition
composition against
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69417252T
Other languages
English (en)
Other versions
DE69417252T2 (de
Inventor
Philip Gevas
Stephen Grimes
Stephen Karr
Dov Michaeli
Robert Scibienski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Receptor Biologix Inc
Original Assignee
Aphton Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aphton Corp filed Critical Aphton Corp
Application granted granted Critical
Publication of DE69417252D1 publication Critical patent/DE69417252D1/de
Publication of DE69417252T2 publication Critical patent/DE69417252T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/844—Stomach; intestine
DE69417252T 1993-11-12 1994-11-10 Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 Expired - Lifetime DE69417252T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/151,219 US5468494A (en) 1993-11-12 1993-11-12 Immunogenic compositions against human gastrin 17
PCT/US1994/013205 WO1995013297A2 (en) 1993-11-12 1994-11-10 Improved immunogenic compositions against human gastrin 17

Publications (2)

Publication Number Publication Date
DE69417252D1 true DE69417252D1 (de) 1999-04-22
DE69417252T2 DE69417252T2 (de) 1999-07-08

Family

ID=22537815

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69417252T Expired - Lifetime DE69417252T2 (de) 1993-11-12 1994-11-10 Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17

Country Status (10)

Country Link
US (1) US5468494A (de)
EP (1) EP0728148B1 (de)
JP (1) JP3694893B2 (de)
AT (1) ATE177757T1 (de)
AU (1) AU1179795A (de)
DE (1) DE69417252T2 (de)
DK (1) DK0728148T3 (de)
ES (1) ES2130575T3 (de)
GR (1) GR3029791T3 (de)
WO (1) WO1995013297A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380230B1 (de) * 1989-01-24 1994-11-17 Aphton Corporation Immunogenische Zusammensetzungen gegen Gastrin-Peptide
US6861510B1 (en) * 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
CA2261433A1 (en) * 1993-12-09 1995-06-10 Belinda Sanchez Ramirez Composition comprising autologous epidermal growth factor
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
EP0889735B1 (de) 1996-02-08 2011-04-13 Cancer Advances, Inc., Immunologische methoden zur behandlung von gastrointestinalem krebs
PT981369E (pt) * 1997-05-12 2005-03-31 Aphton Corp Composicoes imunogenicas para o receptor de cck-b/gastrina e metodos para o tratamento de tumores
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
WO1999059612A1 (en) * 1998-05-15 1999-11-25 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
PT1077721E (pt) * 1998-05-15 2007-06-21 Receptor Biologix Inc Prevenção e tratamento da hipergastrinemia.
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
AU745749B2 (en) * 1998-05-15 2002-03-28 Cancer Advances, Inc. Combination therapy for the treatment of tumors
AU770475B2 (en) * 1999-12-23 2004-02-19 Aphton Corporation A stable immunogenic composition for frozen storage
JP2003532740A (ja) * 2000-05-05 2003-11-05 アフトン コーポレーション キメラペプチド免疫原
WO2002076499A2 (en) * 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
CU22999A1 (es) * 2001-12-04 2004-10-12 Centro Inmunologia Molecular Método de tratamiento de enfermedades malignas e infecciosas crónicas
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
AU2002326356A1 (en) * 2001-07-09 2003-01-29 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
AU2003267984A1 (en) * 2002-07-03 2004-01-23 Receptor Biologix, Inc. Liposomal vaccine
US20050169979A1 (en) * 2002-07-03 2005-08-04 Dov Michaeli Liposomal vaccine
US20040247661A1 (en) * 2002-07-03 2004-12-09 Dov Michaeli Liposomal vaccine
JP4689597B2 (ja) 2003-03-28 2011-05-25 レセプター バイオロジックス インク． ガストリンホルモン免疫アッセイ
CA2580965C (en) 2004-09-22 2014-04-08 Receptor Biologix, Inc. Monoclonal antibodies to progastrin
US8143426B2 (en) * 2006-07-24 2012-03-27 Tetralogic Pharmaceuticals Corporation IAP inhibitors
US8609424B2 (en) * 2007-10-26 2013-12-17 Advanced Life Science Institute, Inc. Antibody directed against pro-gastrin releasing peptide, and use thereof
JP5559789B2 (ja) 2008-08-07 2014-07-23 マーシア・ファーマ・インコーポレイテッド アルツハイマー病の処置のための免疫治療組成物
US8283372B2 (en) 2009-07-02 2012-10-09 Tetralogic Pharmaceuticals Corp. 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
US8674064B2 (en) 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
CN101797382B (zh) * 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
GB201121571D0 (en) 2011-12-15 2012-01-25 Astrimmune Ltd Compounds and uses thereof
US10328134B2 (en) 2013-05-21 2019-06-25 Tyg Oncology Ltd. Gastrin peptide immunogenic composition
CA3066756A1 (en) 2017-06-15 2018-12-20 Cancer Advances Inc. Compositions and methods for inducing humoral and cellular immunities against tumors and cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201770A (en) * 1973-05-07 1980-05-06 The Ohio State University Antigenic modification of polypeptides
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
US4894443A (en) * 1984-02-08 1990-01-16 Cetus Corporation Toxin conjugates
US5023077A (en) * 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
EP0380230B1 (de) * 1989-01-24 1994-11-17 Aphton Corporation Immunogenische Zusammensetzungen gegen Gastrin-Peptide
US5120829A (en) * 1989-03-20 1992-06-09 La Jolla Cancer Research Foundation Hydrophobic attachment site for adhesion peptides
US5256542A (en) * 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise

Also Published As

Publication number Publication date
EP0728148B1 (de) 1999-03-17
DK0728148T3 (da) 1999-09-27
JP3694893B2 (ja) 2005-09-14
GR3029791T3 (en) 1999-06-30
EP0728148A1 (de) 1996-08-28
WO1995013297A2 (en) 1995-05-18
JPH09505056A (ja) 1997-05-20
US5468494A (en) 1995-11-21
ATE177757T1 (de) 1999-04-15
WO1995013297A3 (en) 1995-06-15
DE69417252T2 (de) 1999-07-08
AU1179795A (en) 1995-05-29
ES2130575T3 (es) 1999-07-01

Similar Documents

Publication Publication Date Title
DE69417252D1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
IL113812A0 (en) Copolymer-1, pharmaceutical compositions containing it and its use
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
HK1021824A1 (en) Compositions and methods for treating infections using analogues of indolicidin
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
IL126038A0 (en) Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them
GB9108652D0 (en) Immunoreactive compounds
PL330763A1 (en) Insulin preparations containing nacl
SE9101838D0 (sv) Novel peptides and their use
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
ITMI911155A1 (it) Perfluoropolieteri ad elevata viscosita' e basso contenuto di ossigeno perossidico, e procedimento per la loro preparazione
BG103677A (en) Solid mixtures based on sulphonylcarbamides and adjuvants
AU1751892A (en) Novel peptide compositions and uses therefor
MY106352A (en) Hemoregulatory peptides.
AU1384995A (en) Human circulating cytokine cc-1
DE69524971T2 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
IL139604A0 (en) Novel peptides
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
ZA9710254B (en) LH-RH peptide analogues, their uses and pharmaceutical composition containing them.
EP0717618A4 (de) Stabilisierte tablettenformulierung
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
DE69400945D1 (de) Herstellung von Siliziumnitrid-Pulver mit hohem Alpha-Gehalt
GB9604518D0 (en) Novel compounds

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: RECEPTOR BIOLOGIX, INC. (N.D.GES.D. STAATES DE, US

8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted